Literature DB >> 23276378

[Acarbose and propofol: a dangerous combination?].

E Rocha-Honor1, F J Polo-Romero2, P Sánchez-Beteta1, J Martínez-Peguero1, Y Santisteban-López1, J L Beato-Pérez1.   

Abstract

Hepatotoxicity is a rare complication following the use of propofol and can be potentially serious if an early diagnosis is not made. Propofol is being increasingly used in daily practice, not only in surgery, but also in outpatient sedation procedures, such as endoscopy. Acarbose is a well-known drug used in type 2 diabetes treatment, particularly in the early phase. A case is reported on a patient who suffered an acute hepatitis secondary to the use of propofol in ophthalmology surgery, a hepatitis probably enhanced by prior use of acarbose, a drug that also can cause hepatotoxicity. An early diagnosis and it was resolved without complications. This case could contribute to improve pre-anesthetic evaluation of patients who will be undergoing sedation with propofol in order to avoid the possible appearance of hepatitis.
Copyright © 2012 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Acarbosa; Acarbose; Adverse effects; Efectos secundarios; Hepatitis; Propofol

Mesh:

Substances:

Year:  2012        PMID: 23276378     DOI: 10.1016/j.redar.2012.11.003

Source DB:  PubMed          Journal:  Rev Esp Anestesiol Reanim        ISSN: 0034-9356


  1 in total

1.  Propofol-Induced Hepatitis.

Authors:  Hanna Raisi; Thomas Longerich; Bernardo Moreira Assuncao; Sebastian Mueller; Peter Schirmacher; Helmut-Karl Seitz
Journal:  Eur J Case Rep Intern Med       Date:  2020-10-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.